|
[1]TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
|
|
[2]FORNER A,LLOVET JM,BRUIX J.Hepatocellular carcinoma[J].Lancet,2012,379(9822):1245-1255.
|
|
[3] AN HJ,SHIN WY,LEE KY,et al.A comparison of the risk factors of intrahepatic recurrence,early recurrencen,and multiple recurrences after resection for single nodular hepatocellular carcinoma[J].Korean J Hepatobiliary Pancreat Surg,2015,19(3):89-97.
|
|
[4]HUANG ZY,LIANG BY,XIONG M,et al.Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis:a single-center experience in China[J].Ann Surg Oncol,2012,19(8):2515-2525.
|
|
[5] JAEGER J,KOCZAN D,THIESEN HJ,et al.Gene expression signatures for tumor progression,tumor subtype,and tumor thickness in laser-microdissected melanoma tissues[J].Clin Cancer Res,2007,13(3):806-815.
|
|
[6]SU M,LI LQ,PENG T,et al.Comparative proteomic analysis of differentiating multicentric occurrence and intrahepatic metastasis in multinodular hepatocellular carcinoma[J].Chin J Cancer,2010,29(1):52-58.(in Chinese)苏铭,黎乐群,彭涛,等.肝内转移与多中心发生多结节肝癌的比较蛋白质组学分析[J].癌症,2010,29(1):52-58.
|
|
[7]Chinese Society of Liver Cancer Chinese Anti-Cance Liver Cancer Study Group Chinese Society of Hepato Chinese Society of Pathology Chinese Anti-Cancer A,et al.Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China(2015update)[J].J Clin Hepatol,2015,31(6):833-839.(in Chinese)中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015年版)[J].临床肝胆病杂志,2015,31(6):833-839.
|
|
[8] FEO F,PASCALE RM.Multifocal hepatocellular carcinoma:intrahepatic metastasis or multicentric carcinogenesis?[J].Ann Transl Med,2015,3(1):4.
|
|
[9]ZHANG X,LI HM,LIU Z,et al.Loss of heterozygosity and methylation of multiple tumor suppressor genes on chromosome 3 in hepatocellular carcinoma[J].J Gastroenterol,2013,48(1):132-143.
|
|
[10] LI SL,SU M,PENG T,et al.Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients[J].A-sian Pac J Cancer Prev,2013,14(1):217-223.
|
|
[11]SAITTA C,TRIPODI G,BARBERA A,et al.Hepatitis B virus(HBV)DNA integration in patients with occult HBV infection and hepatocellular carcinoma[J].Liver Int,2015,35(10):2311-2317.
|
|
[12] NOMOTO S,YAMASHITA K,KOSHIKAWA K,et al.Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma[J].Clin Cancer Res,2002,8(2):481-487.
|
|
[13]SHENG S,ZHENG J,CUI S,et al.Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene[J].Anticancer Drugs,2015,26(2):227-231.
|
|
[14]MIAO RY,LUO HT,ZHOU HD,et al.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis[J].J Hepatol,2014,61(4):840-849.
|
|
[15]MURAKATA A,TANAKA S,MOGUSHI K,et al.Gene expression signature of the gross morphology in hepatocellular carcinoma[J].Ann Surg,2011,253(1):94-100.
|
|
[16]SHIMADA M,HAMATSU T,YAMASHITA Y,et al.Characteristics of multicentric hepatocellular carcinomas:comparison with intrahepatic metastasis[J].World J Surg,2001,25(8):991-995.
|
|
[17]IKEDA K,ARASE Y,KOBAYASHI M,et al.Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma:a longterm cohort study of 892 patients with viral cirrhosis[J].J Gastroenterol,2003,38(9):865-876.
|
|
[18]LI SL,LI LQ,PENG T,et al.Clinicopathologic characteristics and prognosis in multinodular and multicentric occurrence hepatocellular carcinoma[J].Chin J Gen Surg,2010,25(10):792-796.(in Chinese)李仕来,黎乐群,彭涛,等.多结节多中心性肝细胞肝癌的临床病理特征及预后[J].中华普通外科杂志,2010,25(10):792-796.
|
|
[19]LI SL,LI LQ,PENG T,et al.Identification of cell clonal origin of multinodular hepatocellular carcinoma by analyzing mitochondrial DNA D-Loop region variations[J].Chin J Bases Clin Gen Surg,2010,17(6):567-572.(in Chinese)李仕来,黎乐群,彭涛,等.通过线粒体DNA D-Loop区序列分析鉴别多结节性肝细胞性肝癌细胞克隆起源[J].中国普外基础与临床杂志,2010,17(6):567-572.
|
|
[20]ZHANG H,YUAN SX,DAI SY,et al.Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion[J].World J Surg,2014,38(4):947-957.
|
|
[21]LLOVET JM,BRU C,BRUIX J.Prognosis of hepatocellular carcinoma:the BCLC staging classification[J].Semin Liver Dis,1999,19(3):329-338.
|
|
[22]LIN CT,HSU KF,CHEN TW,et al.Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer(BCLC)stage B hepatocellular carcinoma:change for treatment of choice?[J].World J Surg,2010,34(9):2155-2161.
|
|
[23]TORZILLI G,BELGHITI J,KOKUDO N,et al.A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers:is it adherent to the EASL/AASLDrecommendations?An observational study of the HCC East-West study group[J].Ann Surg,2013,257(5):929-937.
|
|
[24]HUANG J,YAN L,CHENG Z,et al.A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J].Ann Surg,2010,252(6):903-912.
|
|
[25] ZHOU YD,LI HK,CUI YL,et al.The indications for hepatectomy for multinodular hepatocellular carcinoma:experience from a single institution[J].Dig Surg,2015,32(2):82-89.
|
|
[26]NG KK,VAUTHEY JN,PAWLIK T M,et al.Is hepatic resection for large or multinodular hepatocellular carcinoma justified?Results from a multi-institutional database[J].Ann Surg Oncol,2005,12(5):364-373.
|
|
[27]ZHAO WC,ZHANG HB,YANG N,et al.Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma[J].World J Gastroenterol,2012,18(25):3272-3281.
|
|
[28]YIN L,LI H,LI AJ,et al.Partial hepatectomy vs.transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria:a RCT[J].J Hepatol,2014,61(1):82-88.
|
|
[29] YANG XD,PAN LH,WANG L,et al.Systematic review of single large and/or multinodular hepatocellular carcinoma:surgical resection improves survival[J].Asian Pac J cancer Prev,2015,16(13):5541-5547.
|
|
[30]de SANTIBANES E,CLAVIEN PA.Playing Play-Doh to prevent postoperative liver failure:the“ALPPS”approach[J].Ann Surg,2012,255(3):415-417.
|
|
[31]GOH BK,CHOW PK,TEO JY,et al.Number of nodules,Child-Pugh status,margin positivity,and microvascular invasion,but not tumor size,are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma[J].J Gastrointest Surg,2014,18(8):1477-1485.
|
|
[32] YAN YQ,LI J,HUANG L.How many liver resections for multinodular hepatocellular carcinoma are not radical resections?2015 ASCO Annual Meeting,2015[C].J Clin Oncol(Meeting Abstracts),2015,33(15Suppl):e15163.
|
|
[33]LI T,YIN JK,DU XL,et al.Microwave coagulation combined with hepatectomy in treatment of hepatocellular carcinoma[J].J Surg Concepts Pract,2014,19(5):459-463.(in Chinese)李涛,阴继凯,杜锡林,等.微波固化联合肝癌根治术治疗肝细胞癌的研究[J].外科理论与实践,2014,19(5):459-463.
|
|
[34]XING FJ,LI L,ZHOU ZY.Professor Zhou Zhong-ying's experience on the treatment of liver cancer by complex decoction[J].Jilin J Tradit Chin Med,2014,34(1):22-25.(in Chinese)邢风举,李柳,周仲瑛.周仲瑛教授应用复法大方治疗肝癌[J].吉林中医药,2014,34(1):22-25.
|
DownLoad: